The primary objective of this trial was to assess the impact of minocycline and creatine on the progression of PD and determine if it was futile or non-futile to proceed with further study of these agents. In the study, 200 people with early, untreated PD were equally randomized to receive minocycline, creatine, and a placebo. The study found that both creatine and minocycline should be considered for Phase III trials to determine if they alter the long-term progression of PD.
Where is the Phase 3 trial? Minocycline a... - Cure Parkinson's
Where is the Phase 3 trial? Minocycline and Creatine
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Caffeine and progression of Parkinson’s disease: A deleterious interaction with Creatine
I should research his claims about Creatine and PD (and Creatine and Hashimoto's) and I found...
Anyone participating in the Buntanetap Phase 3 trial?
novis-bio-announces-first-patient-dosed-in-phase-3-trial-in-patients-with-early-parkinson%E2%80%99s-
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
oval-for-european-union-clinical-trial-sites-for-the-phase-3-study-of-buntanetap-for-the-treatment-o
First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's
grounded on positive findings from a placebo-controlled Phase 2a clinical trial (NCT04524351) that...
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
Summary
We conducted a double-blinded phase I clinical trial to establish whether...
Phase 3 Positive Topline Results for Tavapadon 
Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
Anxious to hear any updates from Annovis Bio Butanetap phase 3 trial cohorts
Phase 2 Mesenchymal Stem Cell Trial in USA
Stemregen in clinical trial
